Biochemistry

  1. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

    1. Berta Canal
    2. Allison W. McClure
    3. Joseph F. Curran
    4. Mary Wu
    5. Rachel Ulferts
    6. Florian Weissmann
    7. Jingkun Zeng
    8. Agustina P. Bertolin
    9. Jennifer C. Milligan
    10. Souradeep Basu
    11. Lucy S. Drury
    12. Tom D. Deegan
    13. Ryo Fujisawa
    14. Emma L. Roberts
    15. Clovis Basier
    16. Karim Labib
    17. Rupert Beale
    18. Michael Howell
    19. John F.X. Diffley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies

    1. Lee A. Armstrong
    2. Sven M. Lange
    3. Virginia Dee Cesare
    4. Stephen P. Matthews
    5. Raja Sekhar Nirujogi
    6. Isobel Cole
    7. Anthony Hope
    8. Fraser Cunningham
    9. Rachel Toth
    10. Rukmini Mukherjee
    11. Denisa Bojkova
    12. Franz Gruber
    13. David Gray
    14. Paul G. Wyatt
    15. Jindrich Cinatl
    16. Ivan Dikic
    17. Paul Davies
    18. Yogesh Kulathu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  3. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity

    1. Sang Ho Park
    2. Haley Siddiqi
    3. Daniela V. Castro
    4. Anna A. De Angelis
    5. Aaron L. Oom
    6. Charlotte A. Stoneham
    7. Mary K. Lewinski
    8. Alex E. Clark
    9. Ben A. Croker
    10. Aaron F. Carlin
    11. John Guatelli
    12. Stanley J. Opella

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells

    1. Christoph Gstöttner
    2. Tao Zhang
    3. Anja Resemann
    4. Sophia Ruben
    5. Stuart Pengelley
    6. Detlev Suckau
    7. Tim Welsink
    8. Manfred Wuhrer
    9. Elena Domínguez-Vega

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients.

    1. K. Cereceda
    2. R. González-Stegmaier
    3. JL. Briones
    4. C. Selman
    5. A. Aguirre
    6. G. Valenzuela-Nieto
    7. C. Caglevic
    8. R. Gazitua
    9. A. Rojas-Fernandez
    10. F. Villarroel-Espíndola

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro

    1. Haolin Liu
    2. Pengcheng Wei
    3. Qianqian Zhang
    4. Zhongzhou Chen
    5. Katja Aviszus
    6. Walter Downing
    7. Shelley Peterson
    8. Lyndon Reynoso
    9. Gregory P. Downey
    10. Stephen K. Frankel
    11. John Kappler
    12. Philippa Marrack
    13. Gongyi Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element

    1. Tamar Schlick
    2. Qiyao Zhu
    3. Abhishek Dey
    4. Swati Jain
    5. Shuting Yan
    6. Alain Laederach

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay

    1. Xiong Ding
    2. Kun Yin
    3. Ziyue Li
    4. Rajesh V. Lalla
    5. Enrique Ballesteros
    6. Maroun M. Sfeir
    7. Changchun Liu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Furin cleavage of the SARS-CoV-2 spike is modulated by O -glycosylation

    1. Liping Zhang
    2. Matthew Mann
    3. Zulfeqhar A. Syed
    4. Hayley M. Reynolds
    5. E. Tian
    6. Nadine L. Samara
    7. Darryl C. Zeldin
    8. Lawrence A. Tabak
    9. Kelly G. Ten Hagen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

    1. Nan Wang
    2. Shengli Han
    3. Rui Liu
    4. Liesu Meng
    5. Huaizhen He
    6. Yongjing Zhang
    7. Cheng Wang
    8. Yanni Lv
    9. Jue Wang
    10. Xiaowei Li
    11. Yuanyuan Ding
    12. Jia Fu
    13. Yajing Hou
    14. Wen Lu
    15. Weina Ma
    16. Yingzhuan Zhan
    17. Bingling Dai
    18. Jie Zhang
    19. Xiaoyan Pan
    20. Shiling Hu
    21. Jiapan Gao
    22. Qianqian Jia
    23. Liyang Zhang
    24. Shuai Ge
    25. Saisai Wang
    26. Peida Liang
    27. Tian Hu
    28. Jiayu Lu
    29. Xiangjun Wang
    30. Huaxin Zhou
    31. Wenjing Ta
    32. Yuejin Wang
    33. Shemin Lu
    34. Langchong He

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 85 of 93 Next